Renoprotective effects of dulaglutide in patients with T2DM and CKD

Nat Rev Nephrol. 2018 Nov;14(11):659-660. doi: 10.1038/s41581-018-0055-x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucagon-Like Peptides / analogs & derivatives
  • Humans
  • Immunoglobulin Fc Fragments
  • Insulin Glargine
  • Recombinant Fusion Proteins
  • Renal Insufficiency, Chronic*

Substances

  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • Insulin Glargine
  • Glucagon-Like Peptides
  • dulaglutide